Form 4 for SER Serina Therapeutics, Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-18 · accession 0001493152-24-037714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-20 | 2024-09-18+ | SER | Bailey Gregory | Dir | P - Purchase | $6.13 | +14.4K | 62.2K | +30% | +$88.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-18 | P | A | 2,709 | $6.23 | 50,561 | D | — | — | (F1) The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.18 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price. |
| 2 | Common | Common Stock | 2024-09-19 | P | A | 11,679 | $6.11 | 62,240 | D | — | — | (F2) The price reflects the weighted average purchase price of multiple transactions ranging from a low of $5.96 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price. |